Mark C. McKenna - 12 Dec 2024 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Role: Director
Signature: /s/ Matthew Batters, as attorney-in-fact for Mark McKenna
Issuer symbol: APGE
Transactions as of: 12 Dec 2024
Net transactions value: +$990,775
Form type: 4
Filing time: 16 Dec 2024, 06:00:10 UTC
Previous filing: 19 Jul 2024
Next filing: 08 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APGE	Common Stock	Purchase	$367,650	+7,500		$49.02	7,500	12 Dec 2024	Direct	F1
transaction	APGE	Common Stock	Purchase	$623,125	+12,500	+167%	$49.85	20,000	12 Dec 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported above is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $48.50 to $49.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range.
F2	The price reported above is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $49.6275 to $50.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The price reported above is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $48.50 to $49.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range.

The price reported above is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $49.6275 to $50.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range.